FindMyKOL

George Murakawa, MD

Enriched profile

Somerset Skin Centre

ORCIDNone on fileNPI↗
✓ Full profile
Region🇺🇸 Troy, MI · Midwest · United StatesSpecialtyDermatologyFocusDermatology
Active KOLFindMyKOL type: EliteLatest publicationNone indexedOnline presenceNone verifiedPayments2021–2025NIH funding2000–2003Why? →

George Murakawa is a Dermatology physician affiliated with Somerset Skin Centre. ClinicalTrials.gov lists 3 registered studies with this person as an investigator.

Data verified 23 Oct 2026

Overview

Updated 25 Oct 2026

George Murakawa, MD PHD, is affiliated with Somerset Skin Centre, Troy, MI. The public record shows 50 publications with 1,627 citations (h-index 16), centered on Dermatology. It also documents an investigator role on 3 registered clinical trials, industry payments reported by 39 companies, 1 NIH-funded awards (2000–2003).

  • Top research focus: Dermatology
  • 3 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 39 companies

Generated from the cited public record · current as of 25 Oct 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Acne / Hidradenitis1 trialAcne Vulgaris1 trialPsoriasis / Psoriatic Arthritis1 trialRosacea1 trial

Research focus

OpenAlex concept fingerprint
Dermatology

Drugs & molecules

across trials, industry payments and publications
Dupixentgeneric · DupilumabClinical trials—Industry payments211Publications—Ilumyageneric · TildrakizumabClinical trials—Industry payments88Publications—Cosentyxgeneric · SecukinumabClinical trials—Industry payments73Publications—Tremfyageneric · GuselkumabClinical trials—Industry payments63Publications—Adbrygeneric · TralokinumabClinical trials—Industry payments59Publications—Poteligeogeneric · MogamulizumabClinical trials—Industry payments42Publications—Libtayogeneric · CemiplimabClinical trials—Industry payments41Publications—Nemluviogeneric · NemolizumabClinical trials—Industry payments37Publications—Rinvoqgeneric · UpadacitinibClinical trials—Industry payments34Publications—Bimzelxgeneric · BimekizumabClinical trials—Industry payments22Publications—Cimziageneric · Certolizumab pegolClinical trials—Industry payments22Publications—Akliefgeneric · TrifaroteneClinical trials—Industry payments19Publications—

Works with

trial sponsors and companies reporting payments
Regeneron Healthcare Solutions, Inc.Clinical trials—Industry payments116Genzyme CorporationClinical trials—Industry payments108Sun Pharmaceutical Industries Inc.Clinical trials—Industry payments99Novartis Pharmaceuticals CorporationClinical trials—Industry payments90Galderma Laboratories, L.P.Clinical trials—Industry payments85LEO Pharma Inc.Clinical trials—Industry payments78Janssen Biotech, Inc.Clinical trials—Industry payments62Abbvie Inc.Clinical trials—Industry payments60UCB, Inc.Clinical trials—Industry payments46Kyowa Kirin, Inc.Clinical trials—Industry payments42Lilly USA, LLCClinical trials—Industry payments19Incyte CorporationClinical trials—Industry payments16Arcutis Biotherapeutics, Inc.Clinical trials—Industry payments14Kerecis LimitedClinical trials—Industry payments13Boehringer Ingelheim Pharmaceuticals, Inc.Clinical trials—Industry payments12Dermavant Sciences, Inc.Clinical trials—Industry payments12ConvaTec Inc.Clinical trials—Industry payments11Imbed Biosciences Inc.Clinical trials—Industry payments11Genentech USA, Inc.Clinical trials—Industry payments10Janssen Scientific Affairs, LLCClinical trials—Industry payments10Pfizer Inc.Clinical trials—Industry payments10Ortho Dermatologics, a division of Bausch Health US, LLCClinical trials—Industry payments7E.R. Squibb & Sons, L.L.C.Clinical trials—Industry payments6Biofrontera Inc.Clinical trials—Industry payments5EPI Health, LLCClinical trials—Industry payments5Amgen Inc.Clinical trials—Industry payments4Helsinn Therapeutics (U.S.), Inc.Clinical trials—Industry payments4Regeneron Pharmaceuticals, Inc.Clinical trials—Industry payments3Sanofi-Aventis U.S. LLCClinical trials—Industry payments3Galderma R&DClinical trials2Industry payments—

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
16h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
3clinical trials

Investigator role on registered studies.

View trials ↓
39companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓
1NIH grants · 2000–2003

Federally funded research awards.

View funding ↓

Contact

No public contact details on file. This person's NPPES record doesn't include a practice address or telephone number. Why? →

Clinical trials

Updated 25 Oct 2026

Listed as an investigator on 3 registered studies on ClinicalTrials.gov. The most recent:

Industry payments

Updated 25 Oct 2026

39 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

All 114 payment records: search, sort and filter.Explore →
View the CMS Open Payments record ↗

NIH funding

Updated 25 Oct 2026

1 NIH research award on record, funded 2000–2003 per NIH RePORTER. The latest:

All 6 award records: search, sort and filter.Explore →

Publications

None on file yet. We only list publications we can confidently match to this person. Why? →

Background & recognition

Updated 25 Oct 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record

Secondary affiliations

appointments beyond the home institution

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.